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The mechanism of bleomycin-induced pulmonary fibrosis is not yet clear. Recent studies have shown that alveolar macrophages (AM) can be stimu-
lated by bleomycin in vitro releasing inflammatory cytokines, suggesting that the interaction of bleomycin with AM is an important step in the drug-
induced fibrotic process. Bleomycin is known to bind DNA and generate oxygen radicals through complexation with Fe2+ and oxygen. To provide
more insight into the cellular oxidative property of bleomycin, we have developed a fluoromicroscopic method using 2',7'-dichlorofluorescin diac-
etate (DCFHDA) as an oxidative fluorescence probe to study the bleomycin-induced intracellular oxidation in rat AM and the inhibition of the oxida-
tion by taurine, a compound known to inhibit the bleomycin-induced fibrosis. Bleomycin at 5 to 20 pg/ml has a moderate stimulatory effect (1.87- to
2.66-fold) on the secretion of superoxide anion. A high concentration of bleomycin (20 pg/ml), however, inhibits cell response to zymosan-induced
secretion of superoxide anion. At 4 pg/ml, bleomycin has no effect on cell membrane integrity or morphology but results in a significant increase in
intracellular oxidation. This oxidative process is Fe2-dependent and is accompanied by an increase in intracellular calcium (35 nM). Both the intracel-
lular oxidation and calcium rise induced by internalized bleomycin are inhibited by pretreatment of cells with varying concentrations of taurine (25,
125, and 187.5 pM). The inhibitory effect on intracellular oxidation was found to be 36, 57, and 60%, respectively. These results demonstrate a stim-
ulation-inhibition relationship between bleomycin and taurine on the cellular oxidation at a subcytotoxic dose of bleomycin, suggesting that the oxida-
tive effect of the intracellular bleomycin-Fe2+ complex is important in the initiation of the fibrotic process. - Environ Health Perspect 102(Suppl
10):91-96 (1994)
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Introduction
The pulmonary system is most susceptible
to oxygen radical-induced diseases due to
its constant exposure to the highest oxygen
tension, and the potential encounters with
oxidant gases such as ozone, nitrogen
oxides, and toxic doses of dust particles.
The lung is also a well-perfused organ and
thereby vulnerable to the effect of circulat-
ing xenobiotics such as paraquat, and,
bleomycin, which is known to cause pul-
monary injuries (1). Alveolar macrophages
(AM), which act as a means of defense by
phagocytizing inhaled dust particles and
microorganisms while increasing produc-
tion ofreactive oxidative species, have been
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shown to play an important role in mecha-
nisms leading to oxidative lung injury and
fibrosis (2-4).
Bleomycin is a glycopeptide antineoplas-
tic agent that acts by forming intracellular
bleomycin-Fe2+ complexes capable of pro-
ducing oxygen free radicals and causing
DNA damage (5,6). The therapeutic value
ofthis drug is greatly limited by its associa-
tion with the development of pulmonary
fibrosis. Although the mechanism bywhich
bleomycin causes fibrosis is not known, the
oxidative property of the drug cannot be
overlooked, particularly in light of the fact
that other fibrotic stimulants such as silica
dust (SiO2) also generates oxygen radicals
(7). Recent studies by Scheule et al. (8)
showed that bleomycin at subcytotoxic
doses induced macrophage production of
interleukin-l1 (IL-1,3) and tumor necrosis
factor a (TNFa) in dose and time-depen-
dent manners, suggesting that the
bleomycin-induced fibrosis involves the
fibrogenic potentiating activities ofalveolar
macrophages. It is possible that the cellular
secretion of elevated levels of cytokines
may be related to the drug's intracellular
oxidative activity.
Several studies have shown that the
bleomycin-induced pulmonary fibrosis in
experimental animals may be blocked by
treatment with exogenous taurine (9,10), a
sulfonic acid naturally occurring in high
concentrations in most mammalian tissues
(11). Although not clear, the action oftau-
rine has been attributed to its oxidant-
inhibitory and membrane stabilizing
properties (11). Recent studies by Banks et
al. (12,13) indicate that there is an active
uptake of taurine by alveolar macrophages
that results in an inhibition of oxidative
cell injury caused by ozone exposure. These
results suggest that taurine may be used to
study the potential relationships between
intracellular oxidative events and the
fibrotic process.
The most significant and deleterious
consequences of oxidation, such as DNA
strand breakage (5), damage to the cyto-
skeleton (14,15), and a rise in intracellular
calcium (16), occur intracellularly and can
lead to a cascade ofcellular events resulting
in cell death. Detection of intracellular
oxygen radicals is difficult as they are
highly reactive and extracellular modes of
detection such as luminol-derived chemilu-
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minescence or electron spin resonance sig-
nals rely on detection ofextracellularly gen-
erated radicals (17) or leakage from a
compromised cell membrane. These meth-
ods may detect injury at a relatively late
stage in its evolution. Alternatively, intra-
cellular oxidation can be monitored using
2',7'-dichlorofluorescin diacetate (DCFH
DA) as a fluorescence probe to provide
information on the initial mechanism of
the oxidative process (18). DCFHDA is a
membrane permanent molecule that can be
hydrolyzed by nonspecific esterases to yield
2',7'-dichlorofluorescin (DCFH), a polar
compound that is retained in intact cells.
Upon oxidation, DCFH is converted to
the highly fluorescent 2',7'-dichlorofluores-
cein (DCF), which remains in intact cells
and can be measured for quantitative
assessment of intracellular oxidation
(19,20). Using this fluorescence probe, we
report in the present study a fluoromicro-
scopic method for the determination of
bleomycin-induced intracellular oxidation
in AM and the inhibition ofthe bleomycin
effect by taurine.
Materials and Methods
Alveolar macrophages were harvested from
male Sprague-Dawley rats (225-250 g,
Hilltop Labs, Scottsdale, PA) by bron-
choalveolar lavage. Rats were anesthetized
by ip injection ofsodium pentobarbital (0.2
g/kg bw). The trachea was cannulated and
the lungs were lavaged 10 times with 8-ml
aliquots of phosphate-buffered saline (145
mM NaCl, 5 mM KCl, 1.9 mM
NaH2PO4, 9.35 mM Na2HPO4, 5.5 mM
glucose, pH 7.4). Lavage cell suspensions
were centrifuged at 5OOgfor 5 min at 4°C.
The cell pellets were then washed twice by
alternate resuspension and centrifugation in
HEPES-buffered medium (145 mM NaCl,
5 mM KCl, 10 mM HEPES, 5.5 mM glu-
cose, 1 mM CaCl2, pH 7.4). Cell viability
was measured by trypan blue exclusion and
was typically found to be >95%. The cell
densitywas adjusted to 3 x 106 cells/ml.
One hundred microliter aliquots ofcell
suspensions obtained as described above
were incubated with 5 pM DCFHDA
(Molecular Probes, Eugene, OR), 2% fetal
bovine serum in HEPES buffer (heat inac-
tivated) (Sigma Chemicals, St. Louis, MO)
for 1 hr on 25-mm glass coverslips.
Measurement ofthe intracellular DCF was
made in the cell monolayer regions with a
density of about 120 cells per observing
area. The use of DCFHDA as an intracel-
lular probe for oxygen radical-mediated
oxidation has been previously reported
(20). Taurine (Sigma) in doses of25, 125,
or 187.5 pM was added to the cells at this
time. Care was taken to ensure that taurine
or serum added did not affect fluorescence
probe uptake. At the end of 1 hr the excess
probe and nonadherent cells were washed
away gently and cells were placed in a well
with the glass coverslips as the bottom of
the well. The oxidation of fluorescene
probe was monitored fluoromicroscopically
by focusing on the cells under a Nikon
Diaphot fluorescence microscope using the
Spex-CM system, and recording the signal
obtained in the single wavelength mode
with the excitation filter set at 450 to 490
nm and emission set at 520 to 560 nm.
Fluorescence signals were obtained at 5-
min intervals. After measurements of basal
fluorescence for 15 min, treatments ofcon-
trol and taurine-pretreated cells with oxida-
tive agents such as 10 pM hydrogen peroxide,
5 pM A23187 (Molecular Probes, Eugene,
OR), or bleomycin (4 pg/ml) were made
and the fluorescence monitored as a func-
tion of time. Cell viability was monitored
during and at the end of each experiment
using propidium iodide (PI, 1 pg/ml) as a
membrane-damage fluorescence probe (21).
For the measurement of intracellular
free calcium (16), AM cultures were incu-
bated with 5 pM Fura-2 AM in HEPES
buffer with 2% FBS for 1 hr at 37°C and
washed with the same buffer to remove free
dye and nonadherent cells. (Stock solution
of Fura-2 AM was made by dispersing 50
pg Fura-2 AM in 100 pl of 20% w/v of
Pluronic F-127 in dimethyl sulfoxide.) The
fluoromicroscopic measurement of Fura-2
was carried out using the Spex-CM system
in the dual wavelength mode. Excitation
light was provided by two monochroma-
tors preset at 340 and 380 nm and selected
in rapid alteration (100 Hz) by a rotating
chopper mirror. Emitted light was col-
lected through a 510-nm interference filter
and photon counted in synchrony with the
chopper so that the signals from the two
excitation wavelengths were stored in sepa-
rate memories of a Spex Datamate micro-
computer. The ratio offluorescence excited
at 340 nm to that at 380 nm was used as
an indicator ofthe intracellular calcium rise
in response to stimulation by 4 pg/ml
bleomycin in the control and taurine-
treated cells. At the end of each experi-
ment, 2 pg/ml digitonin and 10 mM
EGTA were added to ensure the respon-
siveness of the system. Determination of
intracellular calcium concentrations was
made using the fluorescence ratio accord-
ing to the method previously reported (22).
Oxygen consumption was measured
with an oxygraph equipped with a Clark
electrode (23). Rat AM (4x 106) were
preincubated at 37°C in 1.75 ml of
HEPES-buffered medium for 10 min.
After preincubation, the cell suspension
was transferred to a temparature-controlled
chamber (370C) and resting oxygen con-
sumption was monitored. Then 125 pM
taurine was added to determine the effects
of taurine on oxygen consumption. Par-
ticle-stimulated oxygen consumption was
determined by addition of zymosan (2
mg/ml) to cells preincubated for 5 min at
370C in the absence or presence oftaurine.
The oxygraph was calibrated using media
equilibrated with gases of known oxygen
content.
Superoxide anion release was deter-
mined spectrophotometrically at 550 nm as
the reduction of cytochrome c as reported
by Sweeney et al. (24). Briefly, AM (4x 106)
were preincubated at 370C for 10 min in 6
ml ofHEPES-buffered medium containing
0.12 mM cytochrome c. After preincuba-
tion, cells were treated with bleomycin
(1-20 pg/ml) and/or zymosan (2 mg/ml)
and superoxide release measured over the
next 30 min. Absorbance changes were
converted to nmoles of reduced cyto-
chrome c using an extinction coefficient of
18.7 mM-1cmi-
Results
EffectofBleomycin onMacrophage
Oxidative Burst
A common response ofAM to particle and
molecular stimulants, such as silica,
zymosan, and phorbol esters, is the genera-
tion of reactive oxygen species with
increased oxygen consumption. Since
hyperoxic conditions have been shown to
potentiate bleomycin-induced fibrosis (25),
the potential effect of bleomycin on the
secretion of superoxide anion by AM was
investigated. Table 1 shows that 5 to 20
pg/ml bleomycin has a moderate stimula-
tory effect (1.87-2.66 times the control) on
the secretion ofsuperoxide anion by other-
wise nonchallenged (resting) AM. The drug
Table 1. Effect of bleomycin on the secretion of super-
oxide anion from alveolar macrophages.a
Concentration Superoxide release, % control
of bleomycin Resting Zymosan-stimulated
0 100 100
1lpg/ml 183 ± 33 102 ± 8
5pg/ml 266± 26b 95 ± 8
10 pg/ml 187±15b 88± 9
20pg/ml 197±18 70+21b
aMean of seven experiments. bStatistically different
from control.
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(at 20 pg/ml), however, inhibits cell
response to zymosan challenge, a particle
stimulant for AM oxidative burst. These
results do not suggest a significant role of
AM respiratory burst in the bleomycin-
induced oxidant injury, but indicate that
bleomycin is capable ofaltering AM activity
presumably due to its ability to induce
intracellular oxidative events. Indeed,
Scheule et al. (8) show that the interaction
of bleomycin with AM in vitro produced
several effects including a concentration-
dependent decrease in macrophage ability
to secrete superoxide anion in response to
stimulation by phorbol esters, a decrease in
intracellular levels of adenosine 3',5'-cyclic
monophosphate, but a concentration-
dependent increase in the secretion of IL-
I13 and TNF-ca. Their results on the
bleomycin stimulation ofcytokine produc-
tion suggest that AM are involved in the
bleomycin-induced fibrosis.
Determination andCharacterizationof
Intuacellular Oxidation
Because bleomycin acts by binding with
Fe2+ of intracellular sources in the genera-
tion of oxygen free radicals, studies were
carried out to examine whether intracellu-
lar oxidation may be induced by subcyto-
toxic dose ofbleomycin, and ifsuch events
can be correlated with mechanisms related
to cellular injury such as the intracellular
calcium homeostasis, or inhibited by pre-
treatment of cells with taurine. Table 1
shows that bleomycin concentrations of 5
pg/ml or lower exhibit only a moderate
effect on the zymosan-stimulated oxidative
burst activity ofAM, while on resting AM,
a dose of 5 pg/ml exhibited maximum
stimulation. At these concentrations, cells
remain viable and show no morphologic
changes as indicated by scanning electron
micrographs (data not shown). Based on
these results, the measurement of intracel-
lular oxidation was carried out using a con-
centration of4 pg/ml bleomycin.
AM monolayers preloaded with
DCFHDA were prepared for fluoromicro-
scopic examinations. The use ofDCFHDA
as an intracellular probe for oxygen radical-
mediated oxidation has been previously
reported (20). This probe undergoes
deacetylation to form DCFH, which can
be oxidized to yield the fluorescent DCF.
Both DCFH and DCF remain in intracel-
lular spaces in intact cells due to their rela-
tively low lipophilicity. The reactivity of
DCFH with hydrogen peroxide has been
well studied (26). It has also been shown
to react with superoxide anion and
hydroxyl free radicals (19) but is resistant
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Figure 1. Effect of H202 and Fe2, on the intracellular
DCF fluorescence in AM as a function of time. (A)
effect of 10 pM H202; (B) effect of 10 pM H202 in cells
preincubated with 200 pM FeSO4. Arrow indicates
point of addition of H202. Y-axis denotes change in flu-
orescence from the initial time point (cps x 10-5).
to autoxidation (18). Hence, DCFHDA is
a useful probe for the study ofbleomycin-
induced intracellular oxidation. Figure 1
shows the generation of intracellular
fluorescence in macrophages by hydrogen
peroxide in the absence and presence of
200 pM FeSO4. Hydrogen peroxide can
permeate the cell membrane, thereby caus-
ing intracellular oxidation. Visual observa-
tion through the fluorescence microscope
revealed fluorescence trapped within the
cytosol. The hyrogen peroxide effect at the
concentrations used did not cause cell
membrane damage as indicated by absence
2+ ofPI fluorescence. In the presence ofFe
,
intracellular DCF fluorescence reached a
maximum, indicating the generation of
intracellular hydroxyl free radicals through
the Fenton reaction. These results indicate
that the fluoromicroscopic method is sensi-
tive for the determination of intracellular
oxidation caused by oxygen radicals. Figure
2 shows that alveolar macrophages exhibit
a significant increase in their intracellular
DCF fluorescence when treated with 5 pM
of the Ca2+ ionophore A23187. The Ca2+
ionophore is known to initiate a calcium
influx and to result in the activation ofthe
protein kinase C-dependent cytochrome
b-245 kinase (27). The results shown in
Figure 2 suggest that the oxidative process
may be induced by a rise of intracellular
free calcium.
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Figure 2. Induction of intracellular fluorescence in AM
by Ca2+ ionophore A23187. (A) control, (B) 5 pM
A23187. Arrow indicates time of addition of the
ionophore.
EffectofBleomycin andTaurine on
Intracellular Oxidation
Figure 3 shows that treatment ofAM with
4 pg/ml bleomycin resulted in an apprecia-
ble increase in the fluorescence generated.
At this concentration, bleomycin did not
affect cell viability or morphology as
confirmed by the PI exclusion and scan-
ning electron micrographs (data not
shown). The bleomycin-induced increase
1 6
I
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Figure 3. Effect of bleomycin (4 pg/mI) on the intracel-
lular DCF fluorescence in AM. (A) control, (B)
bleomycin-treated. Arrow indicates addition of
bleomycin or sham treatment by addition of an equal
volume of HEPES buffer.
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in intracellular fluorescence appears to fol-
low a time-delayed sigmoidal curve, sug-
gesting events such as internalization and
subsequent activation ofdrug may precede
the increase in DCF fluorescence. This is
likely, since AM have receptors for
bleomycin allowing for the internalization
of the drug molecule (28). Other studies
have shown that bleomycin possesses a
bithiazole ring that can intercalate into the
DNA helix, and Fe binding sites involv-
ing the pyrimidine and imidazole moieties
that are capable ofgenerating oxygen radi-
cals in the vicinity of the DNA molecule
(5,6). The role of Fe in bleomycin-
induced intracellular oxidation is shown in
Figure 4. When AM were concurrently
treated with bleomycin and 200 jiM
FeSO4 (curve C) the intracellular fluores-
cence reached a maximum in a fashion
similar to that of the Fe2+-H202 effect.
This indicates that the internalization of
bleomycin, already complexed with Fe2+
and possibly oxygen, has a strong and
immediate effect on intracellular oxidation.
The complexation of bleomycin with Fe2+
may also facilitate the internalization ofthe
drug as well as Fe2+. As shown in Figure 4,
curve B, when Fe2+ was added after the
bleomycin effect, there is a significant but
2+ relatively moderate increase in the Fe -
related intracellular fluorescence. These
I
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results show that Fe2+ plays a key role in
the cellular oxidative activation of
bleomycin, and that the measurement of
intracellular DCF fluorescence is a direct
indication ofthe drug's pharmacologic and
toxicologic activity.
The effect of taurine on bleomycin-
induced intracellular oxidation was studied
using AM pretreated with 25, 125, or
187.5 PM taurine. Figure 5 shows the typi-
cal fluorescence-time curves measured in
control and taurine-treated cells in
response to bleomycin stimulation. Since
cells exhibit varying basal levels ofintracel-
lular fluorescence due to their phagocytic
property, quantitative evaluations of the
effects of taurine and/or bleomycin on
intracellular fluorescence were made by
measuring the slope changes in response to
bleomycin, expressed as the ratio of drug-
treated slope versus the initial slope of the
fluorescence-time curve, and by measuring
the area under the curve (AUC) corrected
from the basal fluorescence of nontreated
cells. The results are summarized in Table
2. Taurine did not have any appreciable
effect on the oxygen consumption or the
intracellular DCF fluorescence change of
resting AM (data not shown). However, as
can be seen from Table 2, this aminosul-
fonic acid has significant inhibitory effect
on bleomycin-induced intracellular oxida-
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Figure 4. Effect of Fe2+ on the bleomycin-induced
intracellular oxidation. (A) effect of 200 pM FeSO4 at
50 min in the absence of bleomycin; (B) effect of 200
pM FeSO4 added at 50 min after bleomycin exposure
added at 15 min; (C) effect of 4 pg/ml bleomycin in the
presence of 200 pM FeSO4.
Table 2. Effect of taurine on bleomycin-induced intra-
cellular oxidation in alveolar macrophaqes as indicated
bythe formation of DCFfrom DCFHDA.
Taurine, Bleomycin,
pM pg/ml
0 0
0 4
25 4
125 4
187.5 4
Intracellular
fluorescence of DCF
Rb Yield, %c
1.02±0.60 -
3.00± 0.74 100
2.71 ± 0.63 64.2 ± 10.8
1.41 ± 0.74 43.2 ± 9.2
1.78 ± 0.46 39.7 ± 5.4
aMean of four experiments. bR is the ratio of the
slopes of fluorescence curves denoting bleomycin-
induced increase over the control. cCalculated as the
area under the fluorescence curves corrected from con-
trol to indicate bleomycin stimulation.
tion. In cells pretreated with 25 pM tau-
rine, the inhibitory effect was found to be
35%. At higher doses (125 and 187.5 pM),
about 60% of the bleomycin-induced
intracellular oxidation was blocked by
internalized taurine.
The antioxidative effect ofcytoplasmic
levels oftaurine has been observed in lungs
ofhamsters treated with tracheal instillates
of bleomycin (9,10) and in rat lungs
exposed to ozone (12). Taurine is normally
found in millimolar concentrations, espe-
cially in tissues that are excitable and gener-
ate oxidants. Active uptake of taurine by
AM is sodium- and energy-dependent and
can achieve an intracellular concentration
of4.27 mM (13). Studies have shown that
intracellular taurine exists in a rapidly
exchangeable free pool and in a slowly
exchangeable bound pool (29). It is pro-
posed that the antioxidant effect may be
due to the ability of free taurine to react
with hypochlorous acid to form taurine
chloramine (11), and the ability of bound
taurine to exert a stabilizing effect on the
plasma membrane and cause formation of
gap junctions in alveolar epithelia (30).
Both of these effects may contribute to its
inhibitory action on bleomycin-induced
intracellular oxidation.
Effects ofBleomycin andTaurine on
Intraceliular Calcium
Figure 6 shows that bleomycin-induced
intracellular oxidation is accompanied or
preceded by a rapid rise in cytosolic cal-
cium (curve A). This effect, which repre-
sents a moderate increase in calcium
concentration of 35 nM, appears to be
transient and reversible and is inhibited by
pretreatment of cells with 125 and 187.5
pM taurine (curves Band C). The concen-
tration of bleomycin used in these experi-
ments was 4 pg/ml, which did not cause
any membrane damage as indicated by PI
Figure 5. Measurement of intracellular DCF fluores-
cence as a function of time in (A) resting AM, (B) AM
pretreated with 187.5 pM taurine, (C) resting AM stim-
ulated with 4 pg/ml bleomycin, and (D) AM pretreated
with taurine 187.5 pM, stimulated with 4 pg/ml
bleomycin. Arrow indicates time point of addition of
bleomycin or buffer (sham treatment).
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Figure 6. Effect of bleomycin (4 pg/ml) on the intracel-
lular calcium rise as a function of time in (A) resting
AM, (B) AM pretreated with 125 pM taurine, and (C)
AM pretreated with 187.5 pM taurine. An increase in
the ratio of Fura-2 measured at excitation 340 nm and
excitation 380 nm, R340 nm/380 nm, indicates an
increase in intracellular free calcium. Arrow indicates
time of addition of bleomycin.
exclusion examination. Bleomycin is
known to cause an increase in calcium con-
tent in the lungs (31). Taurine, on the
other hand, has been shown to decrease the
cytosolic calcium by increasing calcium
binding to the sarcoplasm in myocytes
(32). The results ofthe present study indi-
cate that the bleomycin-mediated cellular
oxidation is associated with an intracellular
calcium rise, and that these effects can be
blocked by intracellular loading oftaurine,
a compound which has been shown to pre-
vent bleomycin-induced pulmonary fibro-
sis in experimental animals (9,10).
Discussion
The mechanism of bleomycin-induced
fibrosis is not yet clear, but studies suggest
that the generation of oxygen radicals by
the bleomycin-Fe2+ complex may play an
important role in the initiation of the
fibrotic process. There are, however, few
studies regarding the cellular oxidative
events caused by bleomycin. It is also not
clear whether direct oxidant cell injury is
linked to fibrosis. This lack ofinformation
is due, at least in part, to the need ofa sen-
sitive method for the detection of cellular
oxidation at subcytotoxic drug concentra-
tions. The present study reports a fluoromi-
croscopic method using DCFHDA as a
fluorescence probe for the quantitation of
oxygen radical-induced intracellular oxida-
tion. This method is sensitive and allows
one to measure oxidative events in cells that
remain intact and viable. It further offers
the advantage that other events in relation
to the oxidative process such as intracellular
calcium mobilization and membrane
integrity can be concurrently determined by
fluoromicroscopy for mechanistic studies.
Studies have shown that bleomycin
stimulates the macrophage release ofIL- I1
and TNF-oc in vitro, suggesting that the
interaction of bleomycin with AM is an
important step in the mechanism of
bleomycin-induced pulmonary fibrosis (8).
AM have been shown to exhibit high- and
low-affinity binding sites for bleomycin
(28). The results of this study show that
bleomycin has a moderate stimulatory
effect on macrophage production ofsuper-
oxide anion but inhibits the stimulation of
superoxide anion release by zymosan.
These results are consistent with those of
Scheule et al. (8) that show that bleomycin
also inhibits the phorbol ester-mediated
macrophage release of superoxide anion.
These studies indicate that the fibrogenic
activity of bleomycin is probably not due
to the excessive stimulation ofmacrophage
respiratory burst. However, it is clear that
bleomycin interacts with AM and alters the
macrophage function. Given the DNA-
binding and oxidative properties of this
drug, it is possible that the oxidative action
brought upon by the internalized bleo-
mycin is responsible for the cellular pro-
duction offibrogenic cytokines.
The bleomycin-mediated intracellular
oxidation is Fe2+-dependent and occurs in
the absence of extracellular Fe . This sug-
gests that the internalization ofbleomycin is
required for the observed oxidation. The
bleomycin effect is also associated with a
rapid increase in intracellular calcium that
appears to precede the oxidation, suggesting
that intracellular calcium mobilization may
play a role in the internalization ofthe drug.
This is possible since calcium mobilization
is required for the cytoskeletal control of
plasma membrane transport and a com-
pound such as taurine, known to decrease
cytosolic calcium, can serve to stabilize the
plasma membrane. The fact that cellular
loading of taurine prior to the bleomycin
treatment can inhibit both the intracellular
calcium rise and oxidation indicates that
these two events are sequentially related.
Taurine is a naturally occurring sulfur-con-
taining amino acid that has been shown to
have a marked in vivo inhibitory effect on
bleomycin-induced fibrosis (9,10). The
results of the present study demonstrate a
stimulatory and inhibitory relationship of
bleomycin and taurine on macrophage
activity even at a low dose ofbleomycin that
does not cause membrane damage or a
change in cell morphology. This suggests
that the oxidative effect of bleomycin may
play an important role in the initiation of
the bleomycin-mediated fibrotic process.
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